CD28 and rheumatoid arthritis: CD4+CD28−FoxP3+ T-cells, however, were not only observed in RA patients with active disease but also in those in remission, and it is unlikely that CD4+CD28− T-cells are continuously stimulated in patients where all other disease activity parameters are low.